Publications by authors named "Eva Lapp"

Claim this Profile
R
Real-World Evidence of Long-Term Disease Control in HER2-Positive Metastatic Breast Cancer Patients Treated with a First-Line Combination of Trastuzumab and/or Pertuzumab Plus Chemotherapy.
Loïc Chaigneau, Eva Lapp, Taha Jai, Erion Dobi, Berenger Martin

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis